As of May 29, 2025, China Pharma Holdings Inc (CPHI) reports a Current Ratio of 0.65.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of China Pharma Holdings Inc's Current Ratio
Over recent years, China Pharma Holdings Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 0.65 |
| 2023-12-31 | 0.88 |
| 2022-12-31 | 0.47 |
| 2021-12-31 | 0.86 |
| 2020-12-31 | 0.47 |
This gradual decrease highlights how China Pharma Holdings Inc manages its short-term assets and liabilities over time.
Comparing China Pharma Holdings Inc's Current Ratio to Peers
To better understand China Pharma Holdings Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| China Pharma Holdings Inc (CPHI) | 0.65 |
| Titan Pharmaceuticals Inc (TTNP) | 6.08 |
| 48North Cannabis Corp (NRTH.V) | 3.96 |
| Polydex Pharmaceuticals Ltd (POLXF) | 3.73 |
| Sonoma Pharmaceuticals Inc (SNOA) | 3.37 |
| Vivo Cannabis Inc (VIVO.TO) | 2.95 |
Compared to its competitors, China Pharma Holdings Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.